Dr Aaron Hiew Wi Han

Dr. Aaron Hiew Wi Han is a Palliative Medicine Consultant who graduated with a Doctor in Medicine degree from University Kebangsaan Malaysia. He completed his Fellowship in Palliative Medicine with the Ministry of Health Malaysia and practices at Hospital Kuala Lumpur. Dr. Hiew has a strong interest in education and was chair the development group for the Cancer Pain CPG second edition.

 

Ms Adele Woon Pei Ning

Adele is an accomplished nursing leader and researcher with a stellar academic background, holding a Master of Nursing from the National University of Singapore (NUS) and an Advanced Diploma in Nursing (Oncology) from Nanyang Polytechnic. With a Bachelor of Science in Nursing from NUS, she has been a Registered Nurse since 2013, progressing to an Advanced Practice Nurse in 2020. Currently serving as Nurse Clinician and Advanced Practice Nurse at the National Cancer Centre Singapore, providing clinical leadership in holistic patient care. She also leads quality improvement projects and serves a dedicated educator. Adele chairs the Nursing Research and Innovation Committee at NCCS to fostering a culture of innovation, critical thinking, and research competence among her peers. Committed to ongoing professional development, Adele is a testament to excellence in nursing and healthcare.

Dr Agnes Chong Shu Sze

Dr. Agnes is a Clinical Psychologist and Senior Lecturer at Universiti Kebangsaan Malaysia. She holds a PhD in the area Clinical Psychology and has experience in pediatric psycho-oncology, caregiver wellbeing, and neurodevelopmental disorders. Dr. Agnes has participated in multiple research projects, including psychosocial interventions for caregivers of children with cancer. She is a member of several professional bodies, including the Malaysian Society of Clinical Psychology and the Malaysian Association for the Study of Pain, and she is passionate about integrating research and clinical practice to improve psychological support for children and families.

Dr Ahmad Naufal Md Alwi

Dr. Ahmad Naufal Md Alwi is a clinical oncologist who graduated from Melaka Manipal Medical College in 2012. He began his career in the Oncology Department at HWKKS, Likas in 2014 and completed a Master of Clinical Oncology at the University of Malaya in 2023. Since August 2024, he has served as Head of the Radiotherapy & Oncology Unit at HRPZ II. Dr. Ahmad Naufal is also a Visiting Oncologist to HPUSM, Kubang Kerian, and HSIP, Kuala Krai. His research involvement includes multiple clinical trials spanning renal, lung, esophageal, and head & neck cancers.
 

Dr Ahmad Radzi Ahmad Badruddin

Dr. Ahmad Radzi bin Ahmad Badruddin is a leading Medical Oncologist with 37 years of rich experience. His special interest is chemotherapy, cancer treatment, radiotherapy, etc. After completing his MD from Universiti Kebangsaan Malaysia, Malaysia, in 1984, he did DMRT from Royal College of Radiologists, United Kingdom, in 1989 FRCS from Royal College of Surgeons of Ireland, Ireland, in 1991. He aims to provide the best medical treatment to every patient.
 

Dr Aida Abdul Aziz

Dr Aida is a Consultant Thoracic Radiologist at Gleneagles Hospital Johor. She graduated from the University of College Dublin in 2001 and completed her master’s in medicine (Radiology) at University Kebangsaan Malaysia in 2010. She has a Thoracic Radiology Fellowship and does an observership at Royal Brompton Hospital in London.
A member of Speciality Education Subcomittee (SSC) Edu Clinical Radiology of Malaysian Medical Council, has published several scientific articles. Her commitment to advancing the field of thoracic radiology, being president of Malaysian Thoracic Radiology special interest group (MThoR) and council member in Malaysian College Radiology; she has organized various Thoracic Symposiums, encouraging holistic management by bringing together various disciplines from multiple sectors, government, private and higher education in multidisciplinary meetings. Dr Aida has made significant contributions to the medical community through her presentations at various international conferences, including India, Vietnam, Vienna, Austria, Singapore and Korea.

Mr Aizuddin Mohamed Mansor

Currently positioned as a Disability Management Officer for PERKESO. 8 years of service to the organization specializing in managing cases for Return to Work encompassing initial contact for assessing basic disability needs, rehabilitation, work modification & retainment as well as long term plan for current disability and disease.

Background of study is undergraduate for Bachelor of Physiotherapy and Master in Sport Science & Recreation. Completed certification for Certified Disability Management Professional under PERKESO internal examination.
 

Dr Allen Sim Soon Phang

Dr Sim is a compassionate, service-oriented Urologist with a robust experience of over 18 years with advanced academic and clinical background in basic to complex urology cases. Dr Sim was Director of Endourology and Fellowships in Department of Urology, Singapore General Hospital where he practiced for 15 years. He had relocated to Malaysia during COVID-19 and was instrumental in setting-up Urology services in Gleneagles Medini Johor, Malaysia. He was responsible in introducing the first robotic surgical system to Southern Malaysia – Da Vinci Xi. He has performed over 160 cases of robotic surgeries in past 1 year for both benign and malignant conditions. Dr Sim has pioneered minimally invasive treatment of BPH by introducing Prolieve Microwave Thermodilatation to Malaysian patients. Dr Sim was also amongst the first to introduce high power Thulium Laser for stone treatments in Malaysia and he has performed more than 1000 stone surgeries during his time in Johor. Dr Sim is also an recognized robotic and laparoscopic proctor in renowned training academy such as IRCAD, proctored robotic surgeons from Malaysia and Philippines, and has performed live surgeries in Singapore, Thailand, Myanmar and Philippines.
 

Prof Dr Anand Sachithanandan

Professor Dr Anand Sachithanandan is a consultant cardiothoracic surgeon with a special interest in lung cancer. He is the founding president of Lung Cancer Network Malaysia, a disease-centric NGO that seeks to improve care and outcomes for lung cancer patients here through education, awareness, research and advocacy. Under his leadership, LCNM has pioneered several national firsts including: a digital patient guide, a counselling tool for specialists and the first-ever CPG for lung cancer in Malaysia. He has championed and pioneered lung cancer screening here with LDCT, and more recently adoption of AI-CXRs and ctDNA.

Anand is practising at Sunway Medical Center & Subang Jaya Medical Center, and holds clinical professorships in cardiothoracic surgery at Sunway University & University Malaya.
 

Dr Anbarasan Anbazagan

Dr. Anbarasan Anbazagan is a clinical oncologist at the Radiotherapy & Oncology Department of Sabah Women & Children's Hospital, Kota Kinabalu. He earned his Master of Clinical Oncology from the University of Malaya in 2023. Dr. Anbarasan is actively involved in clinical trials at his center and is a committed member of both the Malaysian Oncological Society (MOS) and the European Society of Medical Oncology (ESMO).
 

Datin Ang Chin Fan

Datin Ang Chin Fan is the President of the Breast Cancer Support Group Johor Bahru (BCSGJB), advocating for breast cancer awareness and survivor support. With over 27 years in education, she holds a Master’s in Education (ECE) from the University of Southern Australia. She owns four Tadika Xaris kindergartens, two Taska Xaris nurseries, and manages eight Eye Level Learning Centers in Johor. A representative of the ECCE Council for southern Malaysia and Vice Chairperson of Southern University College, Datin Ang is committed to advancing both early childhood and higher education.

Dr Ang Choon Seong

Dr. Ang Choon Seong is a Medical Oncologist at Sarawak General Hospital. He graduated from the University of Edinburgh, Scotland, in 2010, completed his housemanship at Sarawak General Hospital, and obtained Membership of the Royal College of Physicians (MRCP UK) in 2017. He subsequently underwent three years of advanced medical oncology training at the National Cancer Institute Singapore (NCIS) before returning to Malaysia in January 2024, and has been practicing at Sarawak General Hospital since March 2024. His research interests focus on head and neck cancers, particularly nasopharyngeal carcinoma. He is a subcommittee member of the Asian Clinical Trial Network (ATLAS) Head and Neck Cancers Group, with a strong interest in early-phase clinical trials. Dr. Ang has experience in designing and conducting investigator-initiated studies and is actively involved in industry-sponsored early-phase trials, serving as principal investigator for several ongoing trials at Sarawak General Hospital.
 

Dr Ang Soo Fan

Dr Ang Soo Fan is a medical oncologist leading the Curie Oncology’s services in the Penang Adventist Hospital (PAH), Malaysia. He is currently Head of Department (Adventist Oncology Center) and treats patients across all cancer specialities.

Dr Ang graduated from the University of Malaya, Kuala Lumpur. He obtained the Membership of the Royal College of Physicians (MRCP UK) in 2008 and underwent advanced specialty training in medical oncology at the National Cancer Centre Singapore (NCCS). Prior to joining Curie Oncology, he had practised in the various oncology centres at National University Hospital (NUH), Tan Tock Seng Hospital (TTSH) and KK Women and Children’s Hospital (KKH), and NCCS as a Senior Consultant in the Division of Medical Oncology.

Dr Ang is actively involved in clinical research trials and member of PAH research committee participating in multiple international phase III clinical trials. He has published multiple publication and a key reviewer of several peered-review journals. As a strong advocate of oncology education, he is actively involved in teaching oncology trainees and nurses. Dr Ang has been widely invited to share his experiences at both local and international conferences. In recognition of his efforts in patient care, he received the Singapore Health Quality Service Award in 2012.

Across his medical career, Dr Ang has pioneered many cancer treatment protocols through pharmaceutical-sponsored clinical trials including advanced liver cancer, immunotherapy in resected liver cancer, autologous adoptive T-cell immunotherapy for advanced nasopharyngeal cancer, head and neck cancer, lung cancer, biomarker discovery research, etc.

Dr Angel Kwan Khor Nee

Dr Angel Kwan Khor Nee is a Consultant Clinical Oncologist at Sunway Medical Centre
Ipoh since April 2025.

She obtained her M.B.B.S. and Master of Clinical Oncology at University Malaya.

She was one of the pioneer that set up the Unit Radiotherapy & Oncology in Hospital Raja Permaisuri Bainun, Ipoh. Between Jun 2023 to Mar 2025 while practising at Hospital Raja Permaisuri Bainun, Ipoh, Dr Kwan was the Head of Unit for Radiotherapy and Oncology, and led the Oncology services in Perak.

Her expertise includes systemic therapy and advanced radiotherapy, with key interests in breast, colorectal, gastrointestinal, genitourinary, and neuro-oncology cancers. Dr Kwan is a regular speaker at local conferences, has contributed to numerous clinical research, and is active in professional societies such as MOS, ESMO, ESTRO, and FARO.

Dr Anthony Louis Anak Kindu

Dr. Anthony is a Nuclear Medicine Physician at Institut Kanser Negara, Malaysia. Actively involved in both diagnostic molecular imaging and theragnostic services. With a special interest in internal dosimetry, Dr. Anthony focuses on
optimizing radionuclide therapy through accurate dose estimation to improve clinical outcomes. Passionate about integrating science with patient-centred practice, Dr. Anthony continues to contribute to the development of evidence-based nuclear medicine services.
 

Dr Audi Adawiah Sulaiman Shah

Dr. Audi Adawiah is a Clinical Oncologist at Hospital Kuala Lumpur. She obtained her Master of Clinical Oncology from the University of Malaya in 2021.

Her clinical interests include hepatocellular carcinoma, pancreato-biliary cancer, genitourinary cancer, and gastrointestinal cancer. She leads and contributes to multiple multidisciplinary teams (MDTs) focusing on these subsites.

She is actively involved in clinical research, serving as a principal investigator and sub-investigator in various local and international clinical trials.
She is also an active member of both local and international oncology societies.

Ms Azizan Mohd Isa

Ms. Azizan Mohd Isa was born in October 1968. She began her nursing journey by earning a Diploma in Nursing from KL Nursing College in 1990, followed by a Post Basic Oncology Nursing Certificate in 2002. She furthered her academic qualifications with a Bachelor of Science in Nursing (Critical Care) from Universiti Putra Malaysia (UPM) in 2006 and a Master of Education in Guidance and Counseling from Universiti Teknologi Malaysia (UTM) in 2013.

Her professional development includes a Post Basic Certificate in Hematology Care (Bone Marrow Transplant) completed in 1997 in Sydney, Australia, under a JPA scholarship. In 2013, she also obtained a Certificate in World Enterostomal Therapy Nursing (ET) from University Malaya Medical Centre (UMMC) under a KKM scholarship. She later completed the ASCO Palliative Care Course (KKM, 2022) and was awarded the Certificate of Training of Trainers (TTT) (No. 17757) by HDRc Malaysia in 2025.

Teaching has always been her passion, allowing her to share her extensive knowledge and clinical expertise. After retiring in 2021 as an Oncology Nursing Tutor under the Ministry of Health (KKM), Ms. Azizan continues to contribute to the profession. She currently serves as a freelance lecturer, facilitator, and trainer for the Training of Trainers (ToT) Program and Basic Cancer Care Workshops (JKN KKM), and as an external lecturer for the Post Basic Oncology Nursing Programme at International Medical College (IMC).

Dr Azura Deniel

Dr Azura Deniel is a Consultant Clinical Oncologist at KPJ Ampang Puteri Specialist Hospital. She is currently the Head of Oncology Service in KPJ Healthcare.

She obtained her undergraduate degree, MBBCh, from the University of Wales College of Medicine, Cardiff, United Kingdom and completed her postgraduate training in Master of Clinical Oncology from University of Malaya.

Prior to joining private practice, Dr Azura was the head of department of Radiotherapy & Oncology in Hospital Kuala Lumpur. Throughout her career, Dr Azura is actively involved in training, research and clinical trials. She was also involved the development of various cancers clinical practice guidelines and Ministry of Health Systemic Therapy Protocol 3rd Edition 2016. She is actively involved in training, as well as being an examiner for the Universiti Malaya Master in Clinical Oncology degree programme.

Dr Azura is a life-member of the Malaysian Oncology Society, as well as being a member of the Academy of Medicine of Malaysia and the European Society for Medical Oncology (ESMO).
 

Prof Dr C S Pramesh

Dr CS Pramesh is the Director of the Tata Memorial Hospital and Professor and Head of Thoracic Surgery at the Tata Memorial Centre, Mumbai. He serves on the UICC Board of Directors. He is the convener for the National Cancer Grid, a large network of 370+ cancer centres in India and several other countries (https://ncgindia.org). Pramesh is highly committed to reducing inequities in cancer control and making cancer treatment accessible to all geographic regions and strata of society. He is visiting professor at the Division of Cancer Studies, King’s College London and the Institute of Cancer Policy, King’s Health Partners, London. He serves on the advisory boards of several global organizations including WHO, ASCO, ESMO and the UICC. His research interests include health services research, value-based care, addressing barriers to access, and cancer policy. He is a recipient of the Rachel Pearline global cancer research humanitarian award from the National Cancer Institute, USA.

Dato' Dr Chang Kian Meng

Dato' Dr. Chang Kian Meng is a highly respected haematologist with over 30 years of clinical and transplant experience. He graduated with an MBBS from the University of Malaya and holds esteemed postgraduate qualifications including MRCP (UK), FRCP (London), and FRCPA (Haematology) from Australia. His expertise spans a wide range of haematological conditions, including leukaemias, lymphomas, myelodysplastic syndromes (MDS), multiple myeloma, and coagulation disorders. He is also experienced in performing various forms of blood and marrow stem cell transplants, including autologous, allogeneic, haploidentical, and cord blood procedures. Dr. Chang has served as Head of the Haematology Department and National Advisor for Haematology in Malaysia. He is a Past President of the Malaysian Society of Haematology and has published over 40 international papers. Currently practicing at Sunway Medical Centre, he is multilingual and actively involved in advancing haematology through research and clinical trials.

Dr Chen May Feng

Dr Chen May Feng is currently Clinical Oncologist in Hospital Sultan Ismail, Johor Bahru. She attained her medical degree from University Malaysia Sabah. She graduated with Master of Clinical Oncology from University Malaya in year 2022. She is a member of the Malaysia Oncology Society and ESMO. She is actively involved in clinical trials and have good interest in brachytherapy in gynaecology malignancy.  
 

Dr Cheo Seng Wee

Dr. Cheo Seng Wee is a medical oncologist currently practicing at Hospital Wanita dan Kanak-kanak Sabah. He obtained his medical degree from Universiti Malaysia Sabah in 2012 and became a member of the Royal College of Physicians (UK) in 2016, completing his physician training in 2018. In 2023, he completed a Fellowship in Medical Oncology at the National University Cancer Institute of Singapore. Dr. Cheo has made significant contributions to the field of oncology through numerous publications in both local and international journals. He is also an active investigator in various international clinical trials, with special interest on lung, gastrointestinal, and breast cancers.

Prof Dr Cheong Sok Ching

Professor Cheong is the Chief Scientific Officer at Cancer Research Malaysia. She is also an Adjunct Professor at the Faculty of Dentistry, University of Malaya. Her work aims to improve management and survival of cancer patients through the understanding of the underlying molecular changes, and through the development of novel treatment approaches, focusing on head and neck cancers. Her work includes the development of immunotherapy and the use CRISPR-Cas9 essential screens to identify novel targets for head and neck cancer. In addition, she also focuses on early detection using innovative strategies including the development of novel mobile health tools such as MeMoSA®, enabling early detection of oral cancer. She has received grants from national and international funding bodies including the Newton-Ungku Omar Fund, Newton Fund Impact Scheme, Global Challenges Research Fund and the Ministry of Science, Technology and Innovation SMART Fund, amongst others. In recognition of her research contributions, she has received several national and international scientific awards, including the President’s Award by the International Association of Oral Maxillofacial Pathologist (IAOP), the 8th Underwriters Laboratories-ASEAN-US Science Prize for Women 2022 and The World Academy of Sciences (TWAS) Medal Lecture.
 

Dr Chiam Poh Jeann

Dr Chiam Poh Jeann is a Clinical Oncologist at Hospital Wanita dan Kanak-Kanak Sabah (HWKKS).
 

Dr Chong Chan Teng

Dr Chong Chan Teng is currently a clinical oncologist at Institut Kanser Negara, where he treats all solid organ malignancies as well as part of haematological malignancies that require radiotherapy. He holds a special interest in the management of thoracic, genitourinary, gastrointestinal, and breast cancers. He also participates actively in numerous clinical trials exploring cutting-edge cancer therapies such as immunotherapy, targeted agents, and biosimilars, besides frequently presenting at national conferences on emerging cancer therapies.
 

Dr Chong Kwang Jeat

Dr Chong Kwang Jeat is a Consultant Clinical Oncologist at Mahkota Medical Centre, Melaka, with extensive experience in managing a broad spectrum of cancers. He graduated from Universiti Kebangsaan Malaysia and completed specialist training in Clinical Oncology in Leeds, England. Dr Chong began his career at the Institute of Radiotherapy & Oncology, Hospital Kuala Lumpur, before entering private practice. He is an active member of the American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), European Society for Radiotherapy & Oncology (ESTRO), and the Malaysian Oncological Society (MOS). For Dr Chong, oncology is more than protocols and data — it is both a science and an art: the science demands mastery of evolving evidence and technology; the art demands understanding the human behind the disease and shaping care that heals the whole person.
 

Dr Daniel Chan Boon Yeow

Dr Daniel Chan is a medical oncologist in private practice with Icon Cancer Centre in Singapore.  He was the first to utilise pembrolizumab in South Asia in 2014 and also the first  to discover how to further reduce infusion related reactions from amivantamab in a case series presented at ASCO annual meeting 2023, which was subsequently validated in the SKIPPirr trial in 2025.  He continues to be active in research and presented an oral abstract at ASCO  annual meeting 2025 on combined ctRNA and ctDNA next generation sequencing in a variety of cancers.
 

Dr Daniel Gan Eng Hwee

Dr Daniel Gan Eng Hwee is a Clinical Oncologist at Hospital Canselor Tuanku Muhriz, UKM. He graduated with MBBS from University of Malaya in 2013. He obtained Membership of the Royal College of Physicians (MRCP UK) in 2017. He subsequently received the Master of Clinical Oncology from University of Malaya, followed by the attainment of the Specialty Certificate in Medical Oncology from the Royal College of Physicians UK.

He is regularly involved in multidisciplinary meetings and clinical trials involving lung, genitourinary and central nervous system tumors. He is a member of the Malaysian Oncological Society (MOS) and the European Society of Medical Oncology (ESMO).
 

Dr Daniel Wong Wai Yan

Dr Daniel Wong Wai Yan is a Consultant Clinical Oncologist in private practice in Melaka.
 

Dr David Lee Dai Wee

Dr David Lee is a consultant clinical oncologist at Sunway Medical Center, Subang Jaya. His special interests are in thoracic oncology, head and neck oncology and early phase clinical trials. Dr Lee holds Master of Clinical Oncology from University of Malaya and FRCR (Clinical Oncology). After specialty training, he completed a 12-month fellowship in experimental therapeutics at National Cancer Center Singapore.
 

Clin Assoc Prof David Tai

Clinical Associate Professor David Tai is a Senior Consultant Medical Oncologist at National Cancer Centre Singapore. His area of interest is in gastrointestinal cancers and early developmental therapeutics. 
 

Prof Dr Dejan Juric

Dr Diong Nguk Chai

Dr. Diong Nguk Chai obtained her MBBS Degree from the International Medical University, Malaysia, in 2006. She completed her postgraduate training in General Surgery at Universiti Kebangsaan Malaysia in 2015. She undertook subspecialty training in Thoracic Surgery under the Ministry of Health Malaysia, and at the Koo Foundation Sun Yat-Sen Cancer Center in Taiwan, completing it in 2021.

Currently, Dr. Diong serves as a Consultant in Thoracic and General Surgery at Hospital Sultan Ismail in Johor Bahru. Her clinical interests include Video-Assisted Thoracoscopic Surgery (VATS) and lung cancer. She is a passionate advocate for early detection of lung cancer and actively works to raise awareness among healthcare professionals and the public.
 

Dr Eileen Poon Yi Ling

Dr Eznal Izwadi Mohd Mahidin

Dr. Eznal Izwadi Mohd Mahidin is a Clinical Oncologist at Hospital Kuala Lumpur, having earned his MD in 2007 and a Master's in Clinical Oncology in 2016. His primary interests are in breast, head and neck, gynaecological, and lung malignancies. Dr eznal is part of the working group for the 3rd Edition of the Malaysian CPG for the Management of Breast Cancer and also involved as  Investigator in several clinical trials, including breast cancer related study.

Ms Farah Afrina Ismail

Farah Afrina is a graduate of Universiti Kebangsaan Malaysia, where she completed the Diagnostic Imaging and Radiotherapy (PDR) programme. Born and raised in Johor Bahru, she is currently based in her hometown, working as a Radiation Therapist at KPJ Johor Specialist Hospital.

In her clinical practice, Farah has experience delivering a range of treatment techniques, from 3D Conformal Radiotherapy (3DCRT) to Stereotactic Body Radiotherapy (SBRT), across various anatomical sites. Her introduction to Surface Guided Radiation Therapy (SGRT) began early in her career, particularly through Deep Inspiration Breath Hold (DIBH) and 4DCT workflows. She has since advanced into SGRT-based positioning and has been actively involved in the transition toward tattoo-less protocols.

Dr Flora Chong Li Tze

Dr Flora Chong Li Tze is a Clinical Oncologist and Head of the Radiotherapy and Oncology Department at Hospital Wanita dan Kanak-Kanak Sabah in Kota Kinabalu, Sabah. She is also the Head of the Clinical Research Centre at her hospital as well as Head of Oncology Specialty in Sabah. Her areas of interest include urological cancers and paediatric radiotherapy.
 

Dr Fong Chin Heng

Dr. Fong Chin Heng earned his MD degree from Universiti Sains Malaysia (USM) in 2003 and completed his formal training in the master's program in clinical oncology at Universiti Malaya in 2012. Following his specialization training, Dr. Fong devoted three years of service to Hospital Sultan Ismail in Johor Bahru, before returning to Penang General Hospital in 2015. Dr. Fong undertook a clinical fellowship attachment at Princess Margaret Cancer Center in Toronto, Canada, focusing on innovative treatments for central nervous system tumors and genitourinary cnacers. Currently, Dr. Fong serves as a consultant clinical oncologist at Penang General Hospital and Gleneagles Hospital Penang. He contributes to the education of future clinical oncologists through his involvement in the master of clinical oncology program and the national parallel pathway program.
 

Dr Francis Tieng

Dr. Francis Tieng is a Senior Lecturer in the Department of Clinical Oncology, Faculty of Medicine, University of Malaya. He is the founding chair of the “Masterclass of Cancer Molecular Biology,” launched in 2025 as an annual initiative for Master of Clinical Oncology trainees, open to all interested in cancer molecular biology. His research focuses on cancer, cell culture, single-cell RNA sequencing, and bioinformatics. He has received several awards, including First Prize and Best Poster Award at the YSN-ASM Chrysalis Award 2023, and the Young Researcher Award at the International Microbiome and Diagnostic Forum 2022. He has also chaired academic seminars, scientific talks, and community health events. He is a member of the “Asia Pacific Microbiome & Biomedical Research Network” and the “Association for Single Cell Analysis”.
 

Prof Dr Gerald Prager

Assoc Prof Dr Gokula Kumar Appalanaido

Associate Professor (Dr) Gokula is currently practicing as consultant Radiation Oncologist at Universiti Sains Malaysia (USM) and Penang Adventist Hospital. He completed the 5-year consultant Radiation Oncology training in 2013 under the Royal Australian and New Zealand College Of Radiologists (RANZCR) during which periods he worked at the National University Hospital and Tan Tock Seng Hospital,  Singapore and William Buckland Radiotherapy Centre, Alfred Health, Melbourne.

His primary interest is brachytherapy for liver and tongue. The novel HyBIRT radiotherapy technique for tongue cancer treatment was developed by USM team lead by Prof Gokula. The clinical outcome of the HyBIRT prospective study were presented as a proffered paper at ESTRO2023, ESTRO2024 and ESTRO2025. In the ESTRO2025, the HyBIRT technique received further international recognition and was awarded the top 5% of abstracts at the conference.
 

Dr Hans Alexander Mahendran

Dr Hans Alexander Mahendran is a graduate of Universiti Putra Malaysia for his basic medical degree and completed his Master of Surgery postgraduate studies under Universiti Kebangsaan Malaysia in 2011. He served as a surgeon in Sarawak for three years before returning to Peninsula Malaysia to continue subspecialty training in Upper GI Surgery under the Ministry of Health Malaysia. Upon completion, he has been the lead of the Upper GI Surgical Unit in Hospital Sultanah Aminah Johor Bahru since 2017 overseeing service delivery in the southern peninsula of Malaysia. He is also a clinical lead of the Nutrition Support Therapy Team in HSA and continues his work in managing complex Upper GI cases.
 

Dr Hayani Abdul Wahid

Dr. Hayani Abdul Wahid achieved Master in Clinical Oncology from University Malaya in 2010.

She had more than 20 years of experience in oncology services and had won several best service awards during her practice in Hospital Kuala Lumpur. She is currently a resident consultant in Mahkota Medical Centre. Her special interests include Breast and Gynaecological malignancies and currently active in clinical trials involving novel treatment and biosimilar drugs. She is an active reviewer of Medical Journal of Malaysia and locally she involves in many public and community awareness programmes of breast cancer in Melaka. She also led her centre to become the first hospital being awarded Breast Cancer Clinical Program Certification from Joint Commission Internationals in 2023.

Dr. Hayani holds membership of Malaysian Oncological Society, Academy of Medicine Malaysia and European Society of Medical Oncology.
 

Prof Dr Ho Gwo Fuang

Dr Ho Gwo Fuang is a clinical oncologist at Curie Oncology KL, Kuala Lumpur, Malaysia. He was trained at University of St Andrews and Manchester University 1992-1998; Royal Liverpool Hospital NHS Trust, Barts and The London NHS Trust and The Royal Marsden NHS Trust 1999-2007. He attained his Certificate for Completion of Specialist Training (CCST) in 2007 and joined the Faculty of Medicine at Universiti Malaya 2007. He was a Professor of Clinical Oncology and head of Master of Clinical Oncology training programme 2021-2023. He was appointed Adjunct Professor in the Department of Radiation Oncology, Manipal Academy of Higher Education, Mangalore, India and M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tungku Abdul Rahman, Malaysia 2024. His research interests involve breast, gastrointestinal, and hepatobiliary cancers. He co-authored the Pan-Asian Adapted ESMO Clinical Practice Guidelines for hepatocellular carcinoma (2020) and ASCO Resource Stratified Guideline for Early Detection for Colorectal Cancer (2019) and Treatment of Patients with Early-Stage Colorectal Cancer Resource Stratified Guideline (2019). He is involved in many national and international collaborative research work, as well as the training of new oncologists in Malaysia.

Ms Ho Sweet Lee

Ms Ho Sweet Lee is a seasoned healthcare professional with over two decades of experience in oncology nursing, clinical counseling, education, and healthcare management. A specialist in Oncology Nursing and holder of a Master of Counselling, she currently serves as a Senior Lecturer at Sunway University’s School of Nursing. Her previous leadership roles include Oncology Nurse Educator, Cancer Centre Nurse Manager, Head of Nursing School, and Senior Manager in Human Resources. With deep experience in cancer care, patient education, and cross-cultural clinical environments, she offers valuable perspectives on the role of cultural sensitivity in oncology care. Ms Ho has spoken at numerous national and international conferences, and her dedication to compassionate, inclusive practice continues to inspire the next generation of nurses.
 

Dr Ibrahim Ahmad Fuad

Dr Ibrahim a dedicated sports physician based at Hospital Sultan Ismail Johor Bahru (HSIJB), with a focus on athletic performance, injury prevention, and rehabilitation. He works with athletes across all levels, integrating evidence-based medicine with a holistic approach to care.

He collaborate closely with Majlis Sukan Negeri Johor, the National Sports Institute (ISN), and various local sports associations.

Beyond clinical practice, Dr Ibrahim serve as a speaker at local and international conferences and a trainer for various sports medicine courses.

His work extends beyond sports, promoting physical activity and injury prevention to enhance the overall wellness of the general population through education, advocacy, and community engagement.
 

Dr Izzati Wan Maharuddin

Dr Izzati binti Wan Maharuddin graduated in Masters of Clinical Oncology at the University of Malaya in 2022. She is currently serving as a clinical oncologist in Sarawak General Hospital.
 

Clin Asst Prof Dr Jack Chan Junjie

Dr Jack Chan is Chief Quality Officer and Senior Consultant Medical Oncologist at National Cancer Centre Singapore and KK Women’s and Children’s Hospital, subspecialising in gynaecologic and breast cancers. He is Vice President of Gynecologic Cancer Group Singapore, and Principal Investigator of investigator-initiated and industry-sponsored clinical trials for women’s cancers. Dr Chan also sits on the Japanese Society of Medical Oncology’s International Steering Committee, the European Society of Medical Oncology Congress 2024's Scientific Committee (Gynaecological Cancers track) and Asian Society of Gynecologic Oncology 2024 Meeting’s International Scientific Committee.
 

Dr Jahnavi Kesavamatham

Dr. Jahnavi is a distinguished clinical molecular geneticist with an extensive academic background in Human Genetics. Her doctoral research made a pioneering contribution to the field by establishing India's first national registry for Neonatal Diabetes (NDM) and Maturity Onset Diabetes of the Young (MODY), introducing genetic testing for these conditions in the country. Her post-doctoral research at the National University of Singapore (NUS), made substantial contributions to peer-reviewed studies in Oncology, as well as metabolic and neurogenetics. Dr. Jahnavi has also held leadership positions at renowned genetic diagnostic centers. With over 15 years of experience, she is currently making significant strides in Molecular Genetic Diagnostics at Synapse Laboratory, Malaysia.
 

Dr Janatul Madinah Wahabi

Dr. Janatul Madinah Binti Wahabi is a medical physicist with experience working across various systems, including the Varian and Elekta radiotherapy ecosystems. She has been actively involved in data collection, equipment commissioning, and the verification of treatment techniques ranging from conformal radiotherapy to advanced treatments. She is passionate about quality assurance programs in radiotherapy, focusing on the overall treatment process rather than limiting her scope to medical physics alone.
 

Dr Jong Wei Loong

Dr. Jong is a Medical Physicist at Icon Cancer Centre Singapore. He holds a PhD from the University of Malaya and is certified by the International Medical Physics Certification Board (IMPCB).

With previous experience at Proton Therapy Singapore and clinical roles in New Zealand and Malaysia, Dr. Jong brings a wealth of expertise to his work. He is actively involved in both clinical practice and research, having authored and co-authored several peer-reviewed articles. Additionally, he frequently presents at professional conferences and industry events. He also supports regional radiotherapy setup and implementation.


 

Assoc Prof Dr Kanjana Shotelersuk

Dr. Kanjana Shotelersuk obtained her medical degree from Chulalongkorn University in Bangkok, Thailand, in 1992. After receiving her Thai board certification in Radiation Oncology in 1995, she served as a visiting fellow at the NIH in Bethesda, the University of Maryland, and Johns Hopkins University in Baltimore, Maryland, USA from 1996 to 1998.

Currently, she serves as the vice president of the Thai Society of Radiation Oncology (THASTRO) and as a council member of The Federation of Asian Organizations for Radiation Oncology (FARO).

Dr. Kanjana is presently an Associate Professor in Radiation Oncology at Chulalongkorn University in Bangkok, Thailand. Her research interests include radiation therapy for pediatric cancer, breast cancer, and lung cancer.

Dr Katherine Teh Hooi Lay

Dr Katherine Teh Hooi Lay is a highly accomplished Consultant Clinical Oncologist with extensive experience in the medical field. She holds a Doctor of Medicine (MD) from UCSI University and a Master of Clinical Oncology (MCO) from University Malaya. Her career spans roles as a Oncology Trainee, and Clinical Oncologist in various hospitals, including Hospital Sultan Ismail and currently practicing at Gleneagles Hospital Johor.

She is an active member of several professional societies, such as the Malaysian Oncological Society and the European Society For Medical Oncology. Dr Katherine Teh has also held significant roles in organizing committees for oncology-related events and has been a speaker at numerous conferences.

She initiated the establishment of the Liver Cancer Multidisciplinary Team (MDT) meeting for the state of Johor, aiming to enhance collaborative care and improve patient outcomes in the region. Her research contributions include being the primary investigator for multiple clinical trials and
publishing studies on cancer treatment. She has received several certifications and awards, highlighting her dedication and expertise in the field.

Dr Khairiyah Sidek

Dr. Khairiyah Sidek is a Consultant Clinical Oncologist at Hospital Canselor Tuanku Muhriz, Kuala Lumpur, with extensive experience in radiotherapy, chemotherapy, and multidisciplinary cancer care. She obtained her MBBS (2007) and Master’s in Clinical Oncology (2017) from the University of Malaya. Her career spans over 18 years, including roles as Lecturer and Clinical Oncologist at Universiti Teknologi MARA and as an Honorary Supervisor for the Master of Clinical Oncology program at the University of Malaya. Dr. Khairiyah is actively involved in clinical research, with contributions to multiple international oncology trials focusing on immunotherapy and targeted treatments. She has presented at numerous national and international conferences, including ESMO, ASCO, and the Malaysian Oncological Society meetings. Passionate about medical education and patient advocacy, she has supervised postgraduate research projects and engaged in community cancer awareness initiatives. She is a member of ESMO, the Academy of Medicine Malaysia, and the Malaysian Oncological Society.
 

Dr Kiley Loh Wei Jen

Dr Kiley Loh is a consultant medical oncologist subspecializing in the field of breast cancers. He practices at Penang Adventist Hospital, is an active clinical researcher in the field of breast cancers, and has a special interest in cancer supportive and survivorship care.   

Dr Kumutha Chalaya

Dr Kumutha Chalaya is a clinical oncologist and currently serving as head of department in Pusat Rawatan Onkologi Hospital Sultan Ismail Johor Bahru. She obtained her MBBS from Melaka Manipal Medical College and completed her masters in clinical oncology at University Of Malaya. She has served as principal and sub investigator in multiple oncology trial.
 

Mrs Latipah Abdul Wahab

Presenter involved in nursing professional with over 20 years of experience in clinical and educational roles. 
Began career as a nurse in 1999 at Hospital Universiti Kebangsaan Malaysia, now known as Hospital Canselor Tuanku Muhriz UKM, worked in the medical and hematology wards.
From 2006 to 2010, served as the Head Nurse for several units in oncology departments, including the Oncology Daycare, Hematology Daycare, Oncology Clinic, Radiotherapy Unit, and the Clinical Research Ward.
In 2010, transitioned to teaching, becoming a Nursing Lecturer at Kolej Kejururawatan Sg. Petani, focused on basic nursing education (Diploma of Nursing) until 2015. 
Moved to the Institut Latihan Kementerian Kesihatan Malaysia in Johor Bahru and has been teaching the Diploma of Nursing and Advanced Diploma in Oncology Care since Mei 2015.
 In addition to teaching role, has been actively involved in the development of the curriculum for the Advanced Diploma in Oncology Care program.
With a strong foundation in both clinical practice and education, presenter is passionate about shaping the future of oncology nursing through work with students and healthcare professionals.

Dr Lim Chun Sen

Dr. Lim Chun Sen is a consultant clinical oncologist who is currently working in Hospital Sultan Ismail, Johor Bahru (HSI JB), sessional in Gleneagles Hospital Medini and KPJ Johor specialist hospital. Dr. Lim obtained his medical degree from  Universiti Malaya in 2005 and Master of Clinical Oncology at Universiti Malaya in 2013. His primary interest is breast, lung, prostate and gynaecology malignancy. He actively participates in international and local  clinical trials. He had published a number of peer review articles.
 

Dr Look Mei Ling

Dr Look Mei Ling is a Palliative Medicine Physician in Hospital Sultanah Aminah. She obtained her MB BCh BAO from the National University of Ireland in 2009, followed by MRCP (UK) in 2013 and Fellowship in Palliative Medicine under the Malaysian Ministry of Health in 2021. She has enjoyed learning and making a difference in various hospitals in Malaysia, including in Sarawak, Johor and Klang Valley, before coming to Johor Bahru. She has a keen interest in research, quality improvement, education and advocacy for palliative care. She is passionate about expanding palliative care services and access across Johor, with the aim of enhancing patient care, improving family support, and fostering greater work satisfaction among healthcare professionals—through stronger connections, clearer communication, and integrated care.

Ms Maheswari Jaganathan

Maheswari Jaganathan, RN, SCM, CLT, CPN, BSN, is a nurse by profession—but a system changemaker by calling. With more than 23 years of experience in oncology, lymphedema therapy, palliative care, and patient navigation, she currently serves as the Deputy Head of the Community Outreach Unit at Cancer Research Malaysia. Maheswari co-founded and led the development operationalization of Malaysia’s first Breast Cancer Patient Navigation Programme, which has since transformed care across eight public hospitals, supporting over 5,000 newly diagnosed women since 2015. By integrating patient navigation programme in the management breast cancer patients, the program has significantly improved the timeliness in diagnosis, completion of recommended treatment, reduced defaulters and increase the supportive care for newly diagnosed breast cancer patients in state referral centres. Her work received internationally recognition in Oct 2024, the World Health Organization cited her model in its “Patient Navigation for Early Detection, Diagnosis and Treatment of Breast Cancer - Technical Brief as a benchmark for delivering comprehensive breast cancer care. In a global recognition of her visionary impact, her appointment as an Acumen Malaysia Fellow in 2020, joining a global network of 2000+ bold, moral leaders who are tackling the root causes of poverty and injustice. Maheswari was chosen for her courage to challenge the status quo in cancer care and her commitment to building equitable health systems from the ground up. Through this fellowship, she became a voice not only for patients but for an entire generation of nurses ready to lead with empathy, purpose, and systems thinking. One of the highest honours in global nursing, Maheswari Jaganathan was named a Top 10 Finalist for the Aster Guardians Global Nursing Award 2025—a distinction earned among more than 100,000 nurses from 199 countries. This prestigious honour celebrates the world’s most exceptional nurses who are not only advancing care but transforming healthcare systems. Maheswari’s selection affirms her position on the global stage as a trailblazer—redefining 21stcentury nursing leadership by transforming nurses into system architects, harnessing data and innovation to close care gaps, and building models of equity that extend nursing influence from clinical ground to national health policy. “While our leadership at the bedside is invaluable, it often limits us to where we are needed— rather than where we could truly lead. I believe nurses are not just caregivers; we are architects of equity and the next generation of system changemakers. Our place is not limited to clinic or inpatient wards, but at the table where decisions are made, systems are shaped, and futures are transformed.”  - Maheswari Jaganathan, Top 10 Finalist for the Aster Guardians Global Nursing Award 2025

Dr Malwinder Singh Sandhu

Dr. Malwinder Singh earned his Bachelor of Medicine and Bachelor of Surgery (M.B.B.S.) from Melaka Manipal Medical College in 2006 and later completed a Master of Clinical Oncology (M.Co) from the University of Malaya in 2015.

He advanced his skills through specialized training in stereotactic radiotherapy (SBRT/SRS/SRT) at the prestigious Tata Memorial Hospital, Mumbai, and further refined his expertise in Gamma Knife Radiosurgery at Na Homolce Hospital, Prague, Czech Republic.

His clinical practice is centered around advanced treatments, including Gamma Knife Radiosurgery for brain tumors and SBRT for prostate and lung cancers. With a special interest in breast, colon, lung, prostate, and brain cancers, he remains dedicated to providing cutting-edge, patient-centered care.

Beyond his clinical work, he actively participates in numerous clinical trials, striving to advance cancer treatment options and ensure that his patients benefit from the latest research and innovations.

His extensive career includes serving as an oncologist in Malaysia’s Ministry of Health, where he contributed significantly at Hospital Sultan Ismail and Hospital Kuala Lumpur. Through his continued efforts in both practice and research, he is committed to making a meaningful impact on cancer care in Malaysia.

Ms Maria Khong

Maria Khong is a seasoned manager in the healthcare industry who upholds empathy for patients and believes that assimilating empathetic communication into daily practice is vital for healthcare organisations’ success.

Throughout her career in healthcare, she has seen the importance of clinical and non-clinical professionals having empathetic skills and ability to understand patients’ feelings to assess their situation and respond accordingly thus creating positive patient experience.

Maria previously held various leadership positions as CEO and COO of hospitals as well as senior positions with not-for-profit organisations, and is currently serving as General Manager of Can-Care, overseeing Malaysia and Singapore operations.

She remains passionate about quality of patient care, having previously taken hospitals through quality accreditations such as Joint Commission International (JCI) and Malaysian Society for Quality in Health (MSQH) accreditation surveys as well as ISO certifications.
 

Ms Mariam Mohd Nasir

A Registered nurse and midwife and obtained her certificate of Wound, Stoma & Continence Care from Princess Margaret Hospital, Hong Kong.

She is the founder and owner of a training center – M&T Network Consultancy Services Sdn Bhd focusing on wound, stoma and continence care and has expanded to more programs for Nurses and Allied Health Professional.
Recently she expanded her business by opening up a Care Centre to train patients and relatives.
She obtained a certificate in Initiative Chronic Wound from Hamburg, Germany and had her clinical in hospital around Germany.  She received full scholarship to attend Leadership program in Global Nursing leadership Institute in Geneva, Switzerland.

Obtained her Bachelor in Nursing Sciences in University of Malaya and Master in Business Administration in University Technology Mara.

She was the Chief Nursing Officer of University Malaya Medical Centre and ex-Chief Operating Officer of Andorra Women & Children Hospital.

Currently she is the CEO & Nurse Consultant of M&T Network Consultancy Services Sdn Bhd and Program Director for the Malaysian Enterostomal Therapy Nursing Education Program (METNEP) and committee member for the education committee in the World Council of Enterostomal Therapist(WCET).

Her motto is – “Learning is a never ending story without limitation and Nurses must belief that they have the ability to do what they want to do”.
 

Assoc Prof Dr Marniza Saad

Assoc Prof Dr Marniza Saad is a clinical oncologist, researcher and educator at University Malaya. Trained in Cardiff and a fellow of Royal College of Radiologists UK, she is passionate about advancing excellence in cancer care through commitment in clinical service, research and education. Known for her enthusiasm and expertise in genitourinary cancer, she is equally committed to mentoring the next generation of oncologists. She has served as trainer, coordinator and examiner for the Master of Clinical Oncology programme at University Malaya, and spearheaded the development of clinical oncology national curriculum. Beyond her scientific and academic achievements, Dr Marniza is driven to deliver world-class cancer treatment to underserved patients in public hospitals, ensuring that innovation reaches those who need it most. Blending medical excellence with deep compassion and a steadfast sense of social responsibility, she makes an impactful figure in the fight against cancer.

Dr Mastura Md. Yusof

Dr Mastura Md.Yusof obtained her Master in Clinical Oncology at Universiti Malaya and Medical Oncology Examination with ESMO.

She is currently a Consultant Clinical Oncologist at Picaso Hospital and Pantai Hospital Kuala Lumpur. A well-respected key opinion leader and educator, she is a visiting lecturer in Clinical Oncology at University Malaya, leads clinical trials and research and has authored numerous publications.

She sits in the Specialty Subcommittee for Education (Academy of Medicine), a Council member of the Academy of Medicine Malaysia, the College of Oncologist and Malaysian Oncological Society. 
She holds consultancy positions in various advisory boards and expert committee such as PAGA-ESMO Guidelines for colorectal and breast cancer, BRCA mutation, national chemotherapy protocols, Clinical Practice Guidelines and Health Technology Assessment for breast cancer. She actively gives lectures at Oncology congresses and to the public, championing cancer causes for the country.

Dr Melisa Lim Seer Yee

Dr Melisa completed her undergraduate studies in 2004 and her training in Radiology specialty in 2013, both from the Faculty of Medicine, University Malaya. She completed her fellowship in Interventional Radiology in Hospital Selayang, Hospital Kuala Lumpur and National Cancer Center, Tokyo, Japan from 2016-2018. Her special interest is in Interventional Oncology. She is currently the head of Interventional Radiology in Interventional Radiology Unit, Hospital Kuala Lumpur.
She previously served as the Honorary Secretary of Malaysian Society of Interventional Radiology (MYSIR) for the term 2020/2022 and 2022/2024. She is currently the Vice-President of MYSIR for the term 2024/2026.
 

Assoc Prof Dr Melvin Chua

Dr. Chua a Clinician-Scientist at the National Cancer Centre Singapore (NCCS) and the Duke-NUS Medical School. He is the Head of Department and Senior Consultant for the Department of Head and Neck and Thoracic Radiation Oncology, Principal Investigator of the Precision Radiotherapeutics and Oncology Programme (PROP) (www.chualabnccs.com); and Director of the Data and Computational Science Hub at NCCS. He is currently Associate Professor (On Tenure) of Duke-NUS Medical School, Singapore; and Visiting Professor of the Zhongnan Hospital of Wuhan University, China.
 

Dato’ Dr Mohamed Ibrahim A. Wahid

Dato’ Dr Mohamed Ibrahim A. Wahid is Medical Director and Consultant Clinical Oncologist at Beacon International Specialist Centre, Petaling Jaya. He earned his MBBCh from the University of Wales and a postgraduate diploma from the Royal College of Radiologists, UK. He established the Cancer Unit at UMMC and served as its first Head of Clinical Oncology. He later joined Pantai Medical Centre and became Beacon Hospital’s Medical Director in 2008. Dr Ibrahim is a former President of MOS, APFOCC, and SEAROG, and served as IASLC Regent for Southeast Asia and Vice President of the College of Radiology. He has authored over 50 publications and frequently speaks at oncology conferences and public health forums. His interests include cutting-edge radiotherapy treatment and novel systemic therapy.

Mr Mohd Farihan Jaffar

Mr. Mohd Farihan Bin Jaffar, 39, is a highly experienced Therapeutic X-ray Technologist (Juru X-ray Terapi Gred U10). He holds a Bachelor’s Degree in Diagnostic Imaging and Radiotherapy (Hons) from Universiti Kebangsaan Malaysia (2013), a Post-Basic Certificate in Computed Tomography (2005), and a Diploma in Radiotherapy (2000). Since 2013, he has been serving at the Department of Radiotherapy and Oncology, National Cancer Institute, Putrajaya. His professional expertise covers specialized procedures such as SRS/SRT, HDR Gynae, and Head and Neck Brachy (since 2005), as well as radiotherapy planning, dosimetry, and CT simulator operation. In addition, he has experience in management and human resource training, including coordinating SRS, SRT, and SBRT activities

 

Mr Mohd Khairul Mohd Zambri

Mr. Mohd Khairul currently serves as the Radiotherapy Manager at Columbia Asia Hospital, Bukit Rimau. He brings extensive experience in establishing radiotherapy departments, having been involved in the setup at both KPJ Ampang Puteri Specialist Hospital and Columbia Asia Hospital - Bukit Rimau.
 

Dr Mohd Roslan Haron

Dr. Mohd Roslan Haron graduated in Cairo, Egypt, in 1981.
He served as a Consultant Clinical Oncologist with the Ministry of Health from 1989 to 2015.
From 2016 to 2024, he worked as a Resident Clinical Oncologist at Gleneagles Hospital Medini.
In 2025, he began serving as a Sessional Clinical Oncologist at KPJ Johor Specialist Hospital, a position he continues to hold.
He is also the Technical Director of TLJCF and currently acts as an ex-officio member and advisor.
In addition, he is a life member of the Malaysian Oncological Society (MOS).

Dr Mothi Babu Ramalingam

Dr Mothi Babu Ramalingam graduated from Madras Medical College, India in 2008. He completed his Internal Medicine Training in 2014 and Singhealth Rehabilitation Medicine Specialty training in 2017 from Singapore. He is currently a Consultant Rehabilitation Physician at Singapore General Hospital and National Cancer Centre, Singapore with interest in Exercise Oncology, Pain management in cancer ,Integrative Medicine and Cancer survivorship. He completed his international observership in Cancer Rehabilitation and Fellowship in Integrative Medicine from Memorial Sloan Kettering Cancer Center , USA. ( 2024) . He is a passionate educator involved in both undergraduate and post graduate medical education.
 

Dr Muhammad Ash Shafhawi Adznan

Dr. Muhammad Ash Shafhawi Adznan is a dedicated colorectal surgeon with a specialized focus on colorectal cancers. Passionate about advancing surgical care, he prioritizes minimally invasive techniques to improve patient recovery and outcomes. He has been part of the team that established the Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (HIPEC) service in Malaysia, providing cutting-edge treatment options for peritoneal carcinomatosis.

His interests also include Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC), offering innovative approaches for complex cases. Committed to continuous learning and applying the latest advancements, Dr. Ash Shafhawi strives to deliver comprehensive, personalized treatment plans that optimize patient quality of life and long-term prognosis.

Prof Dr Myong Cheol Lim

Prof. Dr. Myong Cheol Lim is a gynecologic oncologist with over 20 years of experience, focusing his research on cytoreductive surgery and HIPEC procedures. While his research is being incorporated into clinical practice guidelines such as the NCCN guidelines and ASCO guidelines, he aims to conduct studies that will provide stronger evidence for future recommendations.

Dr Nahjatul Kursyiah Abd Ghafar

Dr Nahjatul graduated from Cardiff University in 2006 and completed her Master of Clinical Oncology training at University Malaya in 2015. She is currently working as a clinical oncologist at Hospital Wanita dan Kanak-Kanak Sabah (Likas). Her tumour sites of interest include cancer of the head and neck, lung, breast and sarcoma.

Dr Najihah Abu Bakar

Dr Najihah Abu Bakar is a Clinical Oncologist currently in Hospital Kuala Lumpur (HKL). She obtained her medical degree in University College Cork, Ireland, and went on to pursue Master in Clinical Oncology from Universiti Malaya. Upon completing her gazettement, she has been tasked to set up Oncology Unit in HRPB, Ipoh. She then returned to her base in HKL to continue her professional journey with special interests in breast, gastrointestinal and head and neck cancer.

Dr Natasha Mohd Hashim

Dr Natasha Mohd Hashim is a Malaysian clinical oncologist who blends compassionate bedside care with thoughtful policy work. Based at KPJ Johor Specialist Hospital, she guides multidisciplinary treatment for gastrointestinal, lung and, above all, breast cancers—a field she pursues with particular passion through patient education and advocacy. Beyond the clinic, she serves on the national Clinical Oncology Specialty Committee (COSCO) and helps adapt ESMO evidence for Asian centres via the Pan-Asian Guideline Adaptations (PAGA) project. As a regular guest lecturer in radiobiology at the University of Malaya, she is appreciated for her dedication to delivering evidence-based, personalised cancer care—touching each patient and inspiring every trainee she meets.

Dr Nesaretnam Barr Kumarakulasinghe

Dr. Nesaretnam Barr Kumarakulasinghe is a Consultant Medical Oncologist with a unique background at the intersection of medicine and technology. Holding a Master's in Health Informatics from the Karolinska Institutet, he is deeply passionate about leveraging AI and machine learning to advance oncological care. As an Associate Officer for the Group Technology Office at the National University Health System and Associate Director for Data, Digital Health & Informatics at the National Cancer Institute of Singapore, his work focuses on bridging the gap between clinical oncology and information science. He has been a primary investigator on several research grants and has published extensively on machine learning models for cancer prognostication and treatment, with a particular interest in geriatric and genitourinary oncology.

Dr Ng Khai Lip

Dr Ng Khai Lip graduated in Nizhny Novgorod State Medical Academy, Russia in 2010,

Obtained MRCP (UK) in 2015

Started Fellowship training in Queen Elizebeth Hospital in 2018

completed fellowship training in 2021.

Currently a Pulmonologist in Hospital Melaka

Has special interest in Interventional Pulmonology, TB , Lung cancer  and Pleural diseases
 

Dr Ng Wan Jun

Dr Wanjun Ng is a palliative care consultant based in Queen Elizabeth Hospital. She graduated from St Bartholomew's School of Medicine & Dentistry, UK and subsequently completed her internal medicine and subspecialty training both locally and in Singapore. Her special interests include advance care planning, clinical ethics and spirituality. She has developed a local ACP programme in Sabah, and is a contributing author to National Advance Care Planning Guide year 2024.  She won 2nd place for Oral presentation at the 8th International Conference for Advance Care Planning, Singapore in year 2023 for ACP work. She continues to champion ACP training and education in Sabah aiming for greater ACP uptake and care concordance among patients with life limiting illnesses. 

Dr Nik Khairol Reza Md Yazin

A Public Health Medicine Specialist registered in the National Specialist Registry (MPM: 35178, NSR: 127591) with expertise in Occupational Health. He currently holds the position of Head, Occupational Safety and Health Sector, Disease Control Division, Ministry of Health Malaysia.

Education
•        M.D.: Universiti Sains Malaysia (1998)
•        Master of Community Medicine (Occupational Health): Universiti Sains Malaysia (2006)
•        Sub-specialty program Ministry of Health (Occupational Health- Epidemiology) (cohort 2018)

Academic Contributions
Actively contributed to the field of public health through academic endeavours:
•        Teaching and Training: has been involved in training and mentoring medical students, junior doctors, and healthcare professionals in various aspects of public health and occupational health.
•        Lectures and Workshops: has delivered lectures and conducted workshops on topics such as epidemiology, health promotion, and occupational health practices.
•        Research Supervision: has supervised research projects, fostering a culture of evidence-based practice within the healthcare community.
•        Paper Presentation: has presented various research findings as an author or co-author at state, national and international conferences, sharing valuable insights with fellow professionals.
•        Paper Publication: has contributed to published works as an author or co-author. These include journal articles, abstracts, proceedings, scientific paper presentations, and other technical presentations. The publications span a range of topics within the field of public health and occupational health.

Work Experience
With over two decades of experience, has served in various capacities within the healthcare system, demonstrating expertise in public health, occupational health, and epidemiology.
 

Prof Dr Nirmala Bhoo Pathy

Prof. Dr. Nirmala Bhoo Pathy is a public health physician and global leader in cancer control based at Universiti Malaya. A passionate advocate for equitable cancer care, she champions patient-centered approaches, especially in low- and middle-income countries. As founder of WeCan@MY and lead investigator of the ASEAN ACTION study, her work has shaped cancer policies across Southeast Asia. Her research appears in The Lancet, Nature Medicine, and Cell Reports Medicine. She contributes to key global efforts, including multiple Lancet Commissions and WHO initiatives, and sits on the board of the Institute of Cancer Policy at King’s College London. A committed mentor, she inspires the next generation to transform cancer care for all.
 

Dr Nisha Mohd Shariff

Dr Nisha is completed her medical degree at the University of Edinburgh and her postgraduate training in clinical oncology at Universiti Malaya.  She became a fellow with the Royal College of Radiologists UK.  She also completed a clinical fellowship in radiation oncology at Princess Margaret Cancer Centre. Her interests include pediatric radiation and head and neck cancers.
 

Ms Noor Naslinda Noor Rizan

A qualified medical physicist with more than 10 years' experience in radiotherapy. Holds a first degree in Biomedical Engineering degree from the University of Malaya before pursuing Physics and Computing in Medicine MSc. from the University of Manchester in United Kingdom. 

Received clinical training as medical physicist at both The Christie Hospital, Manchester and Penang General Hospital before embarking on professional journey as medical physicist at Gleneagles Hospital Penang in 2013. Became an accredited Consultant Physicist in 2019 specializing in LINAC quality assurance and commissioning, supporting hospitals across Malaysia.

Collaborated with Integrated Oncology for Asia (IOC) in providing guidance and training to help establish world-class medical physics practices in Indonesia and Vietnam.
 

Dr Noor Shatirah Mohd Fandi Voon

Dr. Noor Shatirah Mohd Fandi Voon is a Senior Lecturer in the Diagnostic Imaging and Radiotherapy Program at Universiti Kebangsaan Malaysia (UKM). She previously worked as a clinician in radiation therapy for nine years. Her research interests include psycho-oncology, quality of life, and patient education and care for cancer patients.
 

Dr Nor Aniza Azmi

Dr. Nor Aniza Azmi is a senior lecturer and researcher at Universiti Kebangsaan Malaysia, specialising in psycho-oncology, radiotherapy education, and AI-enhanced digital learning. Her research focuses on supportive care training for radiation therapists, and she has led multiple projects on virtual simulation and psychosocial care integration. Dr. Azmi serves as a reviewer and advisor for journals and scientific committees, and has contributed to national frameworks including the Allied Health Professions Act. Her work bridges clinical practice, education, and innovation to enhance cancer care delivery in Malaysia.

Ms Nor Zaipah Sulong

Ms Nor Zaipah binti Sulong serves as the Head Nurse in the Oncology Department at Hospital Sultan Ismail, Johor Bahru since 2021, bringing with her more than 25 years of dedicated nursing experience. She has served in diverse areas including Oncology, Palliative Care, Rehabilitation, Obstetrics, and Orthopaedics at both Hospital Sultanah Aminah and Hospital Sultan Ismail. In 2005, she pursued a Post Basic in Oncology Nursing, strengthening her expertise in cancer care and patient support. Guided by a passion for service and compassion, she is committed to delivering the highest standard of care, supporting patients and families through their most challenging journeys, and inspiring fellow nurses to uphold excellence and integrity in the nursing profession.

Dr Norhidayu Salimin

Dr Norhidayu Salimin earned her MD from Universiti Putra Malaysia and completed her Master of Clinical Oncology (MCO) at University of Malaya in 2021. She currently serves as a clinical oncologist at Institut Kanser Negara (IKN), Putrajaya.

Dr. Norhidayu is actively involved in clinical research as a principal investigator in multiple clinical trials, particularly in the field of breast, upper gastrointestinal and head & neck cancers. She is a core member in the development of stereotactic body radiotherapy (SBRT) services at IKN, working in collaboration with the International Atomic Energy Agency (IAEA).

She is also a postgraduate trainer for the MCO programme and the FRCR (Clinical Oncology) Parallel Pathway. In addition, she is passionate about healthcare quality improvement as part of the State Lean Flying Squad in Ministry of Health, championing Lean Healthcare initiatives in IKN.

Her vision is to enhance the accessibility of specialized cancer care across Malaysia, ensuring that every patient receives dignified and optimal care throughout their cancer journey

Ms Nur Diyana Afrina Hizam

A Medical Physicist at Thomson Hospital Kota Damansara and a PhD candidate at the University of Malaya, where her research focuses on the application of artificial intelligence in radiotherapy. Her research interests include radiation dosimetry, treatment planning, and automation in treatment planning systems. In addition to her clinical responsibilities, she is involved in scripting within treatment planning systems and has taken an active role in TPS beam modeling and validation to support accurate dose calculation and treatment delivery. Diyana has authored and co-authored several peer-reviewed publications and contributes to research initiatives aimed at improving the safety, precision, and quality of radiotherapy.
 

Dr Nur Fadhlina Abdul Satar

Dr Nur Fadhlina Abdul Satar, fondly known as Dr. Nina, is a consultant oncologist at Pantai Hospital Kuala Lumpur. She was a senior lecturer at University Malaya's Clinical Oncology Department, earning the Excellence Service Award in 2023. Trained at University College London and Barts NHS Trusts, UK, she holds a Master's in Clinical Oncology. Passionate about medical education, she contributes to Cancer ECHO UM project and is principal investigator on international clinical trials. Notably, she won the highest research grant procured by University Malaya Medical Centre in 2021. In 2023, she won the Japan Society in Medical Oncology Rising Star in Asia Workshop in Japan. Dr. Nina actively publishes research and speaks at public forums on cancer awareness.
 

Dr Nur Hana Hamzaid

Dr Nur Hana Hamzaid is a Senior Lecturer at the Faculty of Health Sciences, UKM who obtained her doctorate degree from the University of Sydney, Australia in the field of Health Sciences. She is also a Registered Dietitian under the Ministry of Health Malaysia and appointed as a Dietetic Consultant at the Children's Specialist Hospital, Universiti Kebangsaan Malaysia (HPKK). As an academic who is also actively involved in research in the field of nutrition, she has published more than 15 papers (2020-2023) in quartile 1 and 2 journal and is involved as an author for 3 books related to healthy eating. In addition, she has also successfully licensed and commercialized several healthy food products resulting from studies with the research team she led. Internationally, Dr Hana is a member of the International Reference Group (IRG) for the professional collaboration group, International Dysphagia Diet Standardization Initiatives (IDDSI). In addition, she is also a member of the Malaysian Dietetic Association (MDA) and the Malaysian Society of Paediatric Gastroenterology, Hepatology, Nutrition (MySPGHAN).

Ms Nurbaisyah Badaruddin

Ms Nurbaisyah Badaruddin is a certified Stoma Care Nurse with a deep passion for supporting patients in their healing journey. With years of experience in wound and ostomy care, Ms Nurbaisyah Badaruddin is committed to delivering holistic, compassionate, and evidence-based care. She proudly guides her patients to stand with confidence—because for her, nursing is more than a profession, it’s a purpose.

Ms Nurul Farhah Zainudin

Ms Nurul Farhah Binti Zainudin earned her Diploma in Nursing in 2006 from the Ministry of Health, Malaysia. In 2018, she obtained an Advanced Diploma in Oncology Care with a specialisation in Haematology. She is currently pursuing her Bachelor of Nursing Science with Honours and serves as a Specialist Care Nurse in the Haematology Unit at Hospital Sultanah Aminah, Johor Bahru.
 

Ms Nurul Fazreen Mohd Nadzri

Nurul Fazreen binti Mohd Nadzri is a Senior Radiation Therapist at Gleneagles Hospital Kuala Lumpur almost 8 years with extensive experience in advanced radiotherapy techniques, including VMAT, SBRT, DIBH, IGRT, and Gamma Knife procedures. She is proficient in operating Elekta Versa HD, Siemens CT simulators, and MOSAIQ oncology systems, with specialized training in SGRT using the C-RAD system. Nurul Fazreen plays an active role in patient safety, quality assurance, and clinical documentation, and is a key member of the hospital's Environmental, Health and Safety committee. Passionate about education and innovation in radiotherapy, she is also a coordinator for internship students and a regular participant in national conferences and technical workshops.
 

Dr Nurul Iman Fathi

Ms Ong Yoke Ching

Ms. Ong Yoke Ching is the Chief Nursing Officer at KPJ Bandar Dato' Onn Specialist Hospital, Johor Bahru, with over 25 years of experience in oncology nursing, clinical education, and healthcare management. She began her career as a clinical oncology nurse specialist and later transitioned into leadership roles, combining her expertise in patient care, research coordination, and nursing education. Ms. Ong holds a Master of Science in Nursing from the University of South Australia and has contributed extensively to professional development through lectures, publications, and consultancy. She is also an active internal auditor for SIRIM, HACCP, MSQH, and JCI, and is widely respected for her commitment to advancing nursing excellence.

Dr Ooi Kai Yun

Dr Ooi Kai Yun is a clinical oncologist in Icon oncology at Island Hospital. After graduating with a Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of Malaya, Dr. Ooi furthered her medical career by obtaining a Fellowship of the Royal College of Radiologists (FRCR) in Clinical Oncology as she continued to specialize in Oncology as a clinical fellow during her tenure at two renowned institutions in the UK, The Christie NHS Trust and The Royal Marsden NHS Trust. Her goal is to support patients throughout their cancer journey by providing personalized and tailored treatment options.
 

Dr Ooi Po Lin

Dr Ooi Po Lin is a Clinical Oncologist at University Malaya Medical Centre (UMMC) with a special interest in urological, breast, upper and lower gastrointestinal cancers. She is also deeply passionate about medical education and actively contributes to the training and development of future healthcare professionals.
 

Dr Peter Low Qin Jian

Dr. Peter Low Qin Jian is a Medical Oncologist and Internal Medicine Physician currently based at Hospital Sultan Ismail in Johor Bahru, Malaysia. He graduated from University Malaysia Sabah (UMS) in 2012, obtained his Membership of the Royal College of Physicians (UK) in 2016, and completed his internal medicine training in 2018. In 2023, he concluded his fellowship in Medical Oncology at the National University Cancer Institute, Singapore.

Dr. Low has made notable contributions to the fields of internal medicine and oncology through extensive research and publications. He actively participates as an investigator in various international clinical trials. His research interests focus on novel therapeutics and cancer genetics.
 

Prof Dr Pierce Chow Kah Hoe

Pierce Chow graduated MBBS and PhD from the National University of Singapore. He trained in General Surgery at the Singapore General Hospital and won the Chapter of Surgeons Gold Medal at the conjoint M.Med(Surgery)/FRCS(Edinburgh) examination. Following advanced surgical training in Singapore, he completed a clinical Fellowship in Hepato-Pancreato-Biliary Surgery and Liver Transplantation with Professor Russell Strong in Australia and was subsequently appointed Consultant Surgeon at the Singapore General Hospital.

Pierce is currently tenured professor at the Duke-NUS Medical School and director of the Comprehensive Liver Cancer Clinic at the National Cancer Center Singapore. He is an NMRC funded Senior Clinician Scientist and Principal Investigator (PI) of the NMRC National Flagship Program in Liver Cancer, the PLANet study. He is also funded by BMRC to conduct, in collaboration with industry, the prospective cohort study of patients at high risk of developing liver cancer (ELEGANCE). He has authored more than 300 peer-reviewed papers and has published in the Lancet, Cell, JCO, Nature Cancer, Journal of Hepatology, Gut and other top journals.

Besides clinical work and research, Pierce is also very active in medical education. He is the inaugural and current director of the PhD Program in Clinical and Translational Science at the Duke-NUS Medical School Singapore. He was the inaugural director of the pre-clinical Normal Body course in the same medical school and the founding president of the College of Clinician Scientists at the Academy of Medicine Singapore.

Pierce is Protocol Chair of the Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group and has conducted 12 prospective multi-center clinical studies that has enrolled more than 5000 patients from 62 sites across 17 countries and territories in the Asia-Pacific. In recognition of his outstanding work in clinical and translational liver cancer research, Pierce was conferred the NMRC Outstanding Clinician Scientist Award in 2012 and the NMRC Singapore Translational Research (STaR) Investigator Award in 2025. In 2023, he was inducted into Duke-NUS Medical School’s Hall of Master Academic Clinicians.
 

Dr Prathepamalar Yehgambaram

Dr Prathepamalar Yehgambaram is a Clinical Oncologist at Hospital Kuala Lumpur (HKL) with a strong focus on gynaecological, lung, and gastrointestinal cancers. She is an active member of several multidisciplinary teams and is deeply involved in clinical research and trials to advance evidence-based cancer care. Dr. Prathepamalar was instrumental in establishing Image-Guided Brachytherapy (IGBT) services at HKL and is dedicated to training oncology professionals through brachytherapy seminars and workshops.
 

Ms Premala Ponnusamy

Mrs. Premala D/O Ponnusamy is the Head Nurse of Oncology & Palliative Care at the Palliative Care Association of Johor Bahru (PCAJB), where she has led home-based care services since 2014. With over 20 years of nursing experience, she previously served in the Gynaecology and Oncology units at University Malaya Medical Centre. She holds a Diploma in Nursing (University Malaya), a B.Sc (Hons) in Nursing (Northumbria University), and a post-basic certification in Oncology Nursing. She also completed palliative care training with Hospice Malaysia. Passionate about nursing education, oncology, and holistic palliative care, Mrs. Premala is committed to improving quality of life for patients and families through both clinical practice and public health advocacy.
 

Ms Rahayu Ismail

KJ Rahayu Binti Ismail obtained her Diploma in Nursing in 2003 from the Ministry of Health. She completed her Post Basic in Oncology in 2010 and her Advanced Midwifery in 2014. She is currently pursuing her Bachelor of Nursing Science with Honours. Presently, she serves as a Sister in the Hematology Ward at Hospital Sultanah Aminah, Johor Bahru

Dr Ramya Narayanan

Dr Ramya trained in Sydney, Australia, in Medical Oncology across all tumour types. Her current subspeciality interests include the treatment of Gastrointestinal cancers – including colorectal, UGIT, hepatobiliary and pancreas cancers and Breast cancers. Additional interests include the emerging role of personalised therapies and genomics, as well as the interaction of complementary therapies with systemic therapies.

Ramya is a graduate of the University of Sydney and completed her Internal Medicine and Medical Oncology training in Sydney, followed by 2 years of clinical research Breast Cancer Research unit, and a further Clinical Fellowship. She also has experience working at a large clinical trials unit across early phase clinical trials (phase 1 & 2) as well as later phase clinical trials. She has been extensively involved in teaching/academia at multiple universities for the Post graduate Oncology/Internal Medicine curriculum and Undergraduate teaching. 
 

Dr Rangasamy Ramachandran

Dr Rangasamy Ramachandran holds a Master of Clinical Oncology from Universiti Malaya. He pursues his training at prominent cancer institutions including Hospital Kuala Lumpur, UKMMC, UMMC and National Cancer Institute.
Currently he is practising at Hospital Sultan Ismail in Johor Bahru since 2021. He is actively engaged in multiple clinical trials as Principal and Sub-investigator. His fields of interest include brachytherapy for gynaecological tumours, breast, and gastrointestinal tumours.
 

Dr Rasheila Ganapathi

Dr. Rasheila Ganapathi is a Malaysian Paediatric Haemato-Oncologist currently based at Hospital Sultan Ismail, Johor Bahru. She obtained her medical degree from AIMST University, Malaysia, and subsequently earned her Membership in the Royal College of Paediatrics and Child Health (MRCPCH). She completed her subspecialty training in Paediatric Haemato-Oncology at Hospital Tunku Azizah, Kuala Lumpur, and the Royal Children’s Hospital, Melbourne, in 2024, with a special focus on childhood solid tumours and central nervous system tumours.

She hopes to further develop paediatric oncology services in Malaysia, particularly in the field of neuro-oncology, and is passionate about improving early diagnosis, multidisciplinary care, and long-term survivorship outcomes for children with cancer.
 

Prof Dr Ravindran Kanesvaran

Prof Dr Ravindran Kanesvaran is the Chairman and Senior Consultant in the Division of Medical Oncology of the National Cancer Centre Singapore. He is also a Distinguished Professor at Duke-NUS Medical School. His research interests include genitourinary oncology and geriatric oncology. He is the author of several textbook chapters in Geriatric Oncology and published over 250 peer reviewed papers. He is currently the Past President of the Singapore Society of Oncology (SSO) and the Singapore Geriatric Oncology Society. He is the Past President and of the International Society of Geriatric Oncology (SIOG). He is also the Vice Chairman of the Singapore Cancer Society (SCS) and Past Council Member of the European Society of Medical Oncology ( ESMO).
 

Asst Prof Dr Raviteja Miriyala

Dr Ros Suzanna Ahmad Bustamam

Dr. Ros Suzanna Ahmad Bustamam is a senior clinical oncologist and health leader in Malaysia. She currently serves as Head of the Department of Radiotherapy and Oncology at Hospital Kuala Lumpur, the country’s largest public cancer centre, and is the National Head of Service for Radiotherapy and Oncology under the Ministry of Health.

She received her medical degree from the Royal College of Surgeons in Ireland and her Master of Clinical Oncology from the University of Malaya. With over 15 years of experience, she plays a key role in national cancer service planning, policy development, and capacity building across Malaysia.

Dr. Ros Suzanna is actively involved in clinical research, particularly in epigenetics and psychosocial aspects of cancer. She is also a strong advocate for cancer control, contributing to Malaysia’s National Strategic Plan for Cancer Control and leading initiatives across prevention, early detection, treatment, and palliative care.
Her leadership bridges clinical practice, policy, and research, making her a key figure in advancing equitable cancer care in Malaysia and the region.

Dr Roziana Ariffin

Consultant Genetic Pathologist, President Chapter of Genetic Pathology, College of Pathology & President Medical Genetic Society of Malaysia
 

Assoc Prof Dr Rozita Abdul Malik

Assoc Prof Dr Rozita graduated from University of Malaya in year 2000. She completed her training in Clinical Oncology and obtained Master of Clinical Oncology degree in 2009. She was the head of Department of Clinical Oncology, University Malaya Medical Centre from 2015 to 2019. She has special interest in gynaecological cancers, breast cancers, sarcomas and colorectal cancers. She is involved in many clinical trials in gynaecological, breast cancers and colorectal cancers. Her research interest is in brachytherapy in cervical cancer and intraoperative radiotherapy in breast cancer. She is also involved in the training of clinical oncologist in University of Malaya.
 

Prof Dr Samreen Ahmed

Consultant Medical Oncologist, University Hospitals of Leicester NHS Trust

Professor Ahmed has been a Consultant in Medical Oncology since 2006 and qualified in 1994 at the Royal Free Hospital School of Medicine, London (UK). She has a research degree (MD) through Nottingham University and undertook oncology training in Weston Park Hospital (Sheffield), Nottingham City Hospital and the Leicester Royal Infirmary. She is a Fellow of the Royal College of Physicians. Appointed Honorary Chair of Medical Oncology by University of Leicester in 2016.

Honorary secretary for the Association of Cancer Physicians (ACP). Steering Committee Member for British Thoracic Oncology Group BTOG.
Professor Ahmed is the Training Programme Director for Medical Oncology. She is Chief Investigator and local Principal Investigator for a number of clinical trials in breast and lung cancer.
 

Dr Sandya Subramaniam

Dr Sandya Subramaniam is a clinical oncologist at Hospital Kuala Lumpur. She graduated with a Master of Clinical Oncology from University of Malaya and then did a fellowship in advanced radiation oncology at the University of Manitoba, Canada, focusing on genitourinary cancers, neurooncology, sarcomas and pediatric cancers. She is actively involved in multiple clinical trials and numerous interdepartmental multidisciplinary team meetings. Dr Sandya is an active member of local and international oncology societies.

Dr Sapna Nangia

Dr  Sapna Nangia specializes in  radiotherapy for Head-Neck and Breast cancers. 

With over three decades of experience in radiation oncology, she has been one of the early adopters in India of IMRT for head and neck cancers, in 2002-2003, and has a special interest in radiotherapy techniques. 

She holds a patent for a device to facilitate deep-inspiratory-breath-hold radiation and has, along with her team, designed a protocol for DIBH on a Helical Tomotherapy unit, a facility not provided on the unit. 

Dr Nangia has been associated with the Apollo Proton Cancer Centre, Chennai, since its inauguration in 2019 and has set up the first Head-Neck, Skull base,  Breast  and Gynecological cancer Proton Therapy programs in this part of the world. 

Mr Sayyidi Hamzi

Sayyidi Hamzi graduated with a Bachelor’s in Biomedical Science from Management and Science University (MSU) in 2009 and later earned a Master’s in Medical Science (Pathology) from UKM, focusing on HPV genotyping in Malaysian women for vaccination approval in Malaysia. Then he continued his PhD in Medicine (Pathology) on comprehensive genomic profiling in ovarian cancer.

Currently, Sayyidi is the Regional Senior Manager, Deputy Lab Director, and Senior Clinical Scientist at Reference Specialised Laboratory (RSL), Premier Integrated Labs. He serves on multiple advisory and technical boards. He actively participates in national accreditation and quality assurance bodies, including the Malaysian Society of Cytology, Medical Genetics Society of Malaysia, CAP, MSQH, ISO 15189, and MQAP.

His expertise encompasses molecular pathology in solid tumours, liquid biopsy, cytogenetics, infectious diseases, digital pathology, and next-generation sequencing (NGS) technologies, such as CGP, TMB, HRD, WES, and others. A trained cytoscreener, he is also proficient in IHC and histopathology. Focus on cancer research and medical genetics, he collaborates extensively on local and international research projects, contributing to numerous publications and presentations.
 

Prof Dr See Mee Hoong

Professor Dr. See Mee-Hoong is a Consultant Oncoplastic Breast Surgeon and senior lecturer at the University of Malaya. She graduated from UPM, obtained her Master of General Surgery from UM, and completed her Breast Oncoplastic Training at Mahidol University, Thailand, in 2015. A regional leader in minimally invasive and robotic breast cancer surgery, she pioneered these techniques at UMMC, where she currently heads the Breast and Endocrine Surgery Unit. Her clinical interests include Oncoplastic Breast Surgery, Enhanced Recovery After Surgery (ERAS), Minimally Invasive Surgery (MIS), Robotic Surgery, and Intraoperative Radiotherapy (IORT) and AI in diagnosis pathway of breast cancer. She has published over 70 scientific papers and is actively involved in international surgical societies, including IOPBS and IERBS. Dr. See also leads the Asian Breast Surgery Forum (ABSF), a Project ECHO® collaboration that connects 12 Asian countries to advance breast surgical practices. She currently serves as Deputy Head of the Visibility Unit, Faculty of Medicine, University of Malaya.

Dr Shaheenah Dawood

Dr Shaheenah Dawood is a Consultant Medical Oncologist and Professor in Clinical Oncology in the United Arab Emirates. She was trained in medical oncology at McGill University Hospitals in Canada and subspecialized in breast cancer management at MD Anderson Cancer Center. During her training, she was awarded multiple scholar training awards besides ASCO merit awards. Dr Shaheenah has served as an editorial fellow at the New England Journal of Medicine and has an MPH from the Harvard School of Public Health. She has over 100 papers to her credit including 50 peer review original articles, 30 review articles, and 12 book chapters.

Having served as a reviewer for multiple journals including the Journal of Clinical Oncology she is currently leading the oncology clinical trials program at Mediclinic City Hospital, Dubai. She also serves as President of Excellence in Oncology Care (EIOC) annual congress held in Dubai and is Co-Chair of the Asia Pacific Breast Cancer Summit (APBCS), Asia Pacific Gastrointestinal Cancer Summit (APGCS) ,the international BRCA forum (iBRCAf) and Young Women Forum (YWF) from over a decade.
 

Dr Sharon Anne Khor

Dr Sharon Anne Khor graduated as a medical doctor from University Malaya and completed Masters of Rehabilitation Medicine at the same university. She specializes in rehabilitation for patients with traumatic brain injury, stroke, amputation and cancer. She was responsible for setting up the Department of Rehabilitation Medicine in Hospital Sultan Ismail Johor Bahru in 2009 and heads the department. She was appointed as Johor State Rehabilitation Medicine Specialty Head since 2010. She is a sessional consultant at Johor Specialist Hospital since 2021. She was a representative in the Conjoint Board for Masters of Rehabilitation Medicine University Malaya from 2015 to 2020.
 

Ms Sim Lin Tyng

Madam Siti Saadiah Zainal Abidin

Madam Siti Saadiah Binti Zainal Abidin is currently serving as a Sister in Oncology Services at the Oncology Daycare Unit, KPJ Johor Specialist Hospital. With 16 years of dedicated service at KPJ Johor, she has developed extensive expertise in oncology care, particularly in chemotherapy administration, patient education, and supportive care for cancer patients. She holds a Bachelor’s Degree in Nursing, which has further strengthened her clinical knowledge, leadership abilities, and commitment to excellence. Passionate about advancing oncology services, she takes pride in delivering high-quality, compassionate care and, through active collaboration with multidisciplinary teams, continues to work towards enhancing patient outcomes and supporting the development of best practices in cancer treatment and management.

Dr Sow Wen Jen (Jenson)

Dr. Sow Wen Jen (Jenson) is a Clinical Oncologist at Curie Oncology Kuala Lumpur, with expertise in systemic therapy and radiotherapy. He has a special interest in gastrointestinal cancers, including colorectal, upper GI, pancreatic, hepatobiliary, peritoneal, and anal cancers. Dr. Jenson trained in oncology at University Malaya Medical Centre and previously served at the National Cancer Institute (NCI) and in Sabah before entering private practice.
He was a Council Member of the Malaysian Oncological Society (MOS) and Malaysia’s representative in the ESMO Pan-Asian Guidelines Adaptation for colorectal and biliary cancers. He is also a member of ESMO, ASCO, and ESTRO, and is dedicated to advancing personalized, multidisciplinary cancer care in Malaysia.
 

Dr Sri Kisha Subramaniam

Dr Sri Kisha Subramaniam is a Clinical Oncologist and Senior Lecturer at the University Malaya Medical Centre. Earlier in her career, she served as Assistant Director of Vector-Borne Disease Control with the Melaka State Health Department before specializing in oncology. She obtained her Master’s in Clinical Oncology from University Malaya and now serves as part II Coordinator of the Master of Clinical Oncology, alongside her clinical practice. Actively involved in research and clinical trials, she has presented at leading international conferences including MASCC/ISOO, ASCO, and ASCOMOS and was selected for the ASCO Leadership Program for Women in Oncology.
 

Dr Suhana Yusak

As clinical oncologist, Dr Suhana has several years of experience in treating various cancer patients especially breast, gynecological, nasopharyngeal and lung cancer. She has extensive experience on advanced radiotherapy technique such as Intensity Modulated Radiotherapy (IMRT) for head and neck cancers. Graduated with MBBS (2002) and completed her Masters in Clinical Oncology (2012) both from University Malaya, Kuala Lumpur. She registered with the National Specialist Registry Malaysia as Clinical Oncologist since 2015 and at the same time serving as an honorary lecturer and examiner for Masters in Clinical Oncology programme at University of Malaya since 2017.

She has practice her clinical works at Kuala Lumpur Hospital and National Cancer Institute where she initiated the Stereotactic Body Radiotherapy (SBRT) for spine and lung. She collaborated with the urologist to start the prostate brachytherapy services in National Cancer Institute in year 2015. Apart from this she also actively involved in multidisciplinary meeting for oromaxillofacial tumors and panel for nasopharyngeal cancer and other head and neck cancer for the National Chemotherapy Revision, committee member for National Curriculum for Clinical Oncology for University of Malaya, main committee member for development of Post Basic National Curriculum for Radiation Therapist, national project coordinator for International Atomic Energy Agency (IAEA) regional project; Enhancing Stereotactic Body Radiation Therapy for Frequent Cancers. She is also actively involved in multiple clinical research and audit activities for oncology services.

 

Dr Tan Ai Lian

Dr Tan Ai Lian graduated from Chinese Medical University, Taiwan. She was trained in Internal Medicine in National Taiwan University Hospital before returning to Malaysia to serve the public sector.

Dr Tan received her clinical oncology training in Penang General Hospital before being admitted as Fellow by Royal College of Radiologists in Clinical Oncologist (London) in 2015. After that Dr. Tan continue her career in doing attachment in National Cancer Centre Singapore. Currently she is Clinical Oncologist in Penang General Hospital and is also the visiting oncologist in Bagan Specialist Centre.

Her special interest is in lung cancer, head and neck cancers and hepatobiliary cancer . She is currently also actively involvement in several clinical trial in Penang General Hospital . Dr Tan also involved in teaching, she is a trainer in Malaysia Master Clinical Oncology Programme and Parallel Pathway Oncologist Training Programme.
 

Dr Tan Kee Nam

Dr Tan Kee Nam is an internal medicine physician currently undergoing subspecialty training in medical oncology. He earned his medical degree in 2013 and obtained Membership of the Royal College of Physicians of Ireland (MRCPI) in 2017. Presently, he is completing his oncology fellowship at the National University Cancer Institute, Singapore. Dr Tan has a strong clinical and academic interest in genitourinary and gynaecology malignancies, with a focus on advancing personalised cancer care and contributing to research in these fields. His passion lies in improving patient outcomes through evidence-based medicine, multidisciplinary collaboration and compassionate care.
 

Dr Tan Li Kuo

Dr Tan Li Kuo is currently a senior lecturer in Medical Physics in Universiti Malaya, Malaysia. He was previously the head of Biomedical Engineering in University Malaya Medical Centre, Malaysia, for 5 years.
He has co-authored over 60 papers in peer reviewed scientific journals. His research interests include medical imaging, image processing, and artificial intelligence.
To date he has been an active investigator in multiple research projects totalling over RM 700k in grants, with over RM 250k as principal investigator.
 

Dr Tang Shir Ley

Dr. Tang Shir Ley completed her Master’s in Clinical Oncology in 2022 at Universiti Malaya and is currently serving as a Clinical Oncologist at Hospital Raja Permaisuri Bainun (HRPB), Ipoh. She has a strong interest in artificial intelligence (AI) in oncology and has authored a paper comparing the roles of different AI systems in a centaur approach to assist conduct of MDTs in complicated oncology cases.
 

Assoc Prof Dr Tho Lye Mun

Assoc Prof Dr Tho Lye Mun is a Consultant Clinical Oncologist and Head of Oncology at Beacon Hospital who specializes in thoracic cancers. He holds a PhD in molecular oncology from the University of Glasgow and is active in clinical trials. He is the current President of the Lung Cancer Network of Malaysia.
 

Prof Dr Tony Lim Kiat Hon

Prof Tony Lim is Senior Consultant and Chairman, Division of Pathology in Singapore General Hospital and Academic Chair of the SingHealth Duke-NUS Pathology Academic Clinical Programme. He is actively involved in research focusing on molecular genetics, personalised medicine and the study of lung, liver and gastrointestinal diseases, directing many research initiatives which are instrumental in translating discovery into diagnostics. As a Clinical Director in Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Prof Lim collaborates with many industry and non-industry partners, contributing his clinical expertise to numerous research projects leading to new developments and findings published in many peer-reviewed journals. In addition to his research endeavours, Prof Lim is a passionate educator. He holds the position of Clinical Professor in Duke-NUS Medical School and is a Clinical Physician Faculty in the SingHealth Pathology Residency Programme where he plays a pivotal role in shaping the careers of emerging pathologists. Prof Tony Lim been conferred the Kathy Goh Professorship in Pathology on 1 July 2024, which supports research in breast diseases to improve diagnostic, prognostic, and therapeutic accuracy through biomarker discovery.
 

Dr Tun Mohd Azlan Mohamed Nor

Dr Tun Mohd Azlan bin Mohamed Nor obtained his medical degree from Trinity College, Dublin, Ireland in 2010 and later completed his Master of Clinical Oncology at the University of Malaya in 2022. He is currently serving at Hospital Wanita dan Kanak-kanak Sabah, with special clinical interests in upper gastrointestinal, hepatobiliary, and genitourinary cancers.
 

Dr Vaishnavi Jeyasingam

Dr Vaishnavi Jeyasingam graduated with MBBS from University of Malaya, in 2005 and was awarded the Dean’s List. She obtained her Masters in Clinical Oncology from the same institution in 2013 and has been serving as a consultant oncologist at the Radiotherapy and Oncology Department in Hospital Kuala Lumpur the last 13 years. She also does sessionals at Parkcity Medical Center and Subang Jaya Medical Center. Dr Vaishnavi underwent a clinical attachment with the Head and Neck Radiation unit at the Princess Alexandra Hospital in Brisbane, Australia. She is a supervisor and external examiner of the Masters in Clinical Oncology programme, University Malaya. Her areas of special interest include breast, head and neck and hematology malignancies.  Dr Vaishnavi has been a panel member for several clinical practice guideline committees and patient access programs.  
 

Dr Venkata Pradeep Babu Koyyala

Dr. Venkata Pradeep Babu Koyyala is the Director of Shankara Cancer and Research Institute, Tezpur, Assam. A gold medalist in MBBS from AMC, he earned his MD in General Medicine and a Doctorate in Medical Oncology. He has previously served as Head of Medical Oncology at ACCF (TATA Trusts) and Assistant Professor at TMC Visakhapatnam. Dr. Koyyala holds European Certification in Medical Oncology and is a Fellow of the European Society of Medical Oncology (Canada) and FUICC (Italy). A former consultant at Rajiv Gandhi Cancer Institute, he is also the Associate Editor of the Indian Journal of Medical and Pediatric Oncology and Principal Investigator of the GENESIS Project on inherited cancers in Northeast India.
 

Dr Vickee Rajeswaran

Graduated from Bandung, Indonesia in 2011 and has since served with the Ministry of health Malaysia as house officer and medical officer until 2018, after which she completed her Master’s Degree in Clinical Oncology at the University of Malaya in June 2022.  She is currently a clinical oncologist practising in Sultan Ismail Hospital, Johor Bahru. Special interests include urooncology, paediatric radiation oncology, stereotactic radiosurgery and palliative care in oncology.
 

Adj Prof Dr Voon Pei Jye

Dr Voon Pei Jye is the Head and Consultant Medical Oncologist, Department of Radiotherapy and Oncology, Hospital Umum Sarawak (Sarawak General Hospital). He is also an Adjunct Professor Universiti Malaysia Sarawak (UNIMAS). 
He read medicine at UNIMAS. He subsequently obtained his MRCP (United Kingdom) and Master of Medicine (Internal Medicine) from National University of Singapore. Thereafter, he received his advanced specialist training in Medical Oncology from National University Hospital Singapore. He has also completed his Phase 1 Drug Development clinical research fellowship at Princess Margaret Cancer Centre, University of Toronto, Canada.
He is an active investigator for numerous cancer trials encompassing early phase through to late phase studies. He has keen interest in oncology development therapeutic and thoracic oncology. Dr Voon has published in various peer reviewed journals. He is a recipient for Hold’em for Life Oncology Fellowship Award, University of Toronto. He has also won the Scholar Training Award from AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021.

Assoc Prof Dr Wan Zamaniah Wan Ishak

Associate Prof. Dr. Wan Zamaniah Wan Ishak is a Consultant Clinical Oncologist at the University Malaya Medical Centre and University Malaya Specialist Centre, Kuala Lumpur, Malaysia. Current Head of Department Clinical Oncology, FOM, UM. Special interest in head and neck & upper GI cancers

Dr Wong Yoke Fui

Dr Wong Yoke Fui obtained her MBBS year 2005 and Master of Clinical Oncology Year 2014 from University Malaya. She is currently a Clinical Oncologist working at Institut Kanser Negara (National Cancer Institute) since 2014. She hold the post of Head of Clinical Research Center (CRC) IKN since 2016. She is Trainer for Master of Clinical Oncology. Dr Wong involved in multiple clinical trials as PI and Sub-I and awarded as National Top Recruiter year 2018. She is the developmental group for Stereostatic Body Radiotherapy (SBRT) in IKN. Year 2024, appointed as panel of expert (POE) for First in Human (FIH) study for Ministry of Health.

Dr Yap Beng Khiong

Dr Yap Beng Khiong MBChB, MRCP, FRCR, FRCP, CCST (Clinical Oncology UK)

Dr. Yap is a consultant Clinical Oncologist at Oncocare Cancer Centre, Malaysia. He is a council member of the Lung Cancer Network Malaysia. He did his under-graduate and post graduate medical studies in the United Kingdom. He then undertook a clinical fellowship in Radiation Oncology at the University of Toronto, Canada. He was appointed as a consultant Clinical Oncologist at the Christie NHS Foundation Trust, Manchester, England for over 10 years before returning to Malaysia.He was a member of the UK National Cancer Research Institute clinical subgroup designing and conducting clinical trials. He was the chief and principal investigator for a number of clinical trials. He won the first prize in his presentation on Intensity Modulated Radiotherapy for Thyroid Cancers in the 2nd World Thyroid Cancer Congress, Toronto Canada in 2013. One of his area of interests is promoting public awareness on the importance of early cancer diagnosis and treatments.
 

Dr Yeo Geok Gee

Dr Yeo Geok Gee is a clinical oncologist currently practicing in Sarawak General Hospital, Kuching. She obtained her medical degree from University of Malaysia, Sarawak. She completed two years of training in The Christie NHS Foundation Trust, Manchester and obtained her fellowship in Clinical Oncologist of the Royal College of Radiologists in 2023. Dr Yeo actively participates in various international clinical trials, contributing to innovative research focused on improving patient outcomes.

Ms Yoon Sook Yee

Ms. Yoon Sook-Yee, FHGSA is a certified Genetic Counsellor in Malaysia, accredited by the Human Genetics Society of Australasia. She is Head of Genetic Counselling at GENETIX Cancer Research Malaysia and Visiting Genetic Counsellor at University Malaya Medical Centre and several private hospitals. She led the nationwide MaGiC study to improve access to genetic testing for ovarian cancer patients. Her research focuses on hereditary cancers and the psychosocial aspects of testing in multicultural Malaysia. She serves on the IMPAHC Scientific Committee and HUGO Education Committee, and is Vice President of the Genetic Counselling Society Malaysia.
 

Dr Yugarajah Asokumaran

Dr Yugarajah is a medical Oncologist with Oncocare Malaysia, Thomson Hospital Kota Damansara. He did his undergraduate training in SUM and subsequently underwent training in Medical Oncology in National Cancer Institute Singapore. Dr Yuga treats a broad range of solid tumour and has been a co investigator for multiple phase 2 and 3 clinical trial . He served as a Medical Oncologist in Advanced Medical and Dental Institute, USM Penang before joining Oncocare Malaysia, Thomson Hospital as a Medical Oncologist
 

Dr Zaril Harza Zakaria

Dr. Zaril Harza Zakaria is a prominent individual in regulatory affairs, currently serving as the Head of the Investigational Product Section at the National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia. His work significantly impacts clinical research, with a specialized focus on Clinical Trial Import Licence (CTIL) and Clinical Trial Exemption (CTX).

Academically, Dr. Zaril holds a Master of Science in Clinical Research from Cranfield University, UK, and a PhD in Pharmacokinetics from Aston University, UK. Boasting over two decades of experience, he has been instrumental in evaluating investigative products for clinical trials, including vaccines and First-in-Human (FIH) trials within Malaysia. Furthermore, Dr. Zaril is a certified GCP Inspector, diligently upholding ethical and regulatory compliance across various clinical trial sites, bioequivalence centers, and ethics committees throughout Malaysia.